All In MedTech

FDA Clearance Tracker · P950005-S010

CELSIUS DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 5, 2001 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 5, 2001

Approved

Time to decision

301 days

Received Dec 8, 2000. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class II

The decision

FDA number
P950005-S010
Device name
CELSIUS DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER
Applicant location
Irvine, CA
Received
Dec 8, 2000
Decided
Oct 5, 2001
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P950005

Device type

Device class
Class II
Regulation
21 CFR 870.1220
Specialty
Cardiology

Every decision under product code DRF

FDA's approval statement

As written in FDA's record.

APPROVAL FOR EXPANDING THE INDICATIONS FOR USE. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME CELSIUS DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER AND IS INDICATED AS FOLLOWS: THE BIOSENSE WEBSTER CELSIUS DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER AND RELATED ACCESSORIES ARE INDICATED FOR CATHETER-BASED ATRIAL AND VENTRICULAR ELECTROPHYSIOLOGICAL MAPPING AND FOR USE WITH COMPATIBLE RADIOFREQUENCY GENERATORS IN ADULTS AND CHILDREN 4 YEARS OF AGE AND OLDER IN CREATING ENDOCARDIAL LESIONS DURING CARDIAC ABLATION PROCEDURES TO TREAT ARRHYTHMIAS.

Source documents

Other decisions for Biosense Webster, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.